Categories AlphaGraphs, Earnings, LATEST, Technology

Cognex’s revenue and profit declines in Q3, provides weak outlook

As expected, Cognex (CGNX) reported a decline in the bottom and top line numbers for the third quarter sending the shares into the negative territory during the extended market hours on Monday.

The maker of barcode readers’ revenue dropped 13% year-over-year to $232 million and non-GAAP profit per share slumped 24% to 39 cents in the recently ended quarter. GAAP EPS dropped 21% to 45 cents.

For the fourth quarter of 2018, Cognex expects revenue to be between $180 million and $190 million. At the mid-point, this outlook is lower than the company’s long-term growth target due to both the slower spending by customers in China and a lingering headwind from last year’s high level of investment by the large OLED display and smartphone manufacturers.

“While we are pleased with our Q3-18 results, slower spending trends that we are experiencing in China have reduced our revenue outlook for Q4-18,” said CEO Robert Willett.

Cognex Q2 earnings flat; stock gains

Research, Development & Engineering expenses increased 14% from the prior year, due to Cognex’s investment in engineering resources for new product development. Selling, General & Administrative expenses increased 8% due to continued investments in sales resources as well as higher commissions and travel expenses.

Cognex increased its quarterly cash dividend by 11% to $0.05 per share, payable on November 30, 2018, to all shareholders of record as of November 16, 2018. Also, the Board authorized the repurchase of up to $200 million of Cognex stock in open market transactions.

Shares of Cognex, which plunged to a 52-week low ($39.00) during Monday’s regular trading session, closed at $39.61, down 3.95%. After the earnings announcement, the stock continued its poor performance by tanking another 10% in the extended hours of trading.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top